InvestSMART

CurveBeam AI Limited (ASX: CVB) - Announcements

- Current share price for CVB : $0.018

ASX company news and announcements for CurveBeam AI Limited (CVB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CurveBeam AI Limited (CVB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CurveBeam AI Limited (CVB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CurveBeam AI Limited (CVB)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$9 Update - Proposed issue of securities - CVB 28 Jul 2026 5:30PM $0.018 $0.018 fallen by 0%
$9 Update Indicative Timetable for Share Purchase Plan 28 Jul 2026 5:25PM $0.018 $0.018 fallen by 0%
$9 Notice of General Meeting/Proxy Form 21 Jul 2026 4:41PM $0.018 $0.018 fallen by 0%
$9 CVB Investor Deck July 2026 8 Jul 2026 10:59AM $0.019 $0.018 fallen by 5.26%
$9 Quarterly Activities/Appendix 4C Cash Flow Report 8 Jul 2026 9:33AM $0.018 $0.018 fallen by 0%
$9 Proposed issue of securities - CVB 8 Jul 2026 9:30AM $0.018 $0.018 fallen by 0%
$9 Proposed issue of securities - CVB 8 Jul 2026 9:30AM $0.018 $0.018 fallen by 0%
$9 CVB Secures 5M Placement & Announces SPP 8 Jul 2026 9:29AM $0.018 $0.018 fallen by 0%
$9 Change of Director's Interest Notice - Rob LIlley 6 Jul 2026 3:27PM $0.018 $0.018 fallen by 0%
$9 Application for quotation of securities - CVB 6 Jul 2026 2:44PM $0.018 $0.018 fallen by 0%
$9 Application for quotation of securities - CVB 6 Jul 2026 2:41PM $0.018 $0.018 fallen by 0%
$9 Trading Halt 6 Jul 2026 9:09AM $0.018 $0.018 fallen by 0%
$9 Change in substantial holding 18 May 2026 7:07PM $0.056 $0.018 fallen by 67.86%
$9 Q3 FY26 Quarterly Results Investor Webinar 30 Apr 2026 8:14AM $0.060 $0.018 fallen by 70%
$9 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2026 8:14AM $0.060 $0.018 fallen by 70%
$9 Q3 FY26 Quarterly Results Investor Webinar 27 Apr 2026 3:34PM $0.057 $0.018 fallen by 68.42%
$9 Initial Director's Interest Notice - Patrick Fisher 24 Mar 2026 2:44PM $0.045 $0.018 fallen by 60%
$9 CVB to Present at NWR Healthcare Conference 20 Mar 2026 9:28AM $0.052 $0.018 fallen by 65.38%
$9 Notification regarding unquoted securities - CVB 19 Mar 2026 9:11AM $0.057 $0.018 fallen by 68.42%
$9 Independent Non-Executive Director Appointment 19 Mar 2026 9:05AM $0.057 $0.018 fallen by 68.42%
$9 Commentary to App 4D - Dec 2025 Half Year 27 Feb 2026 8:34AM $0.069 $0.018 fallen by 73.91%
$9 Appendix 4D - Interim Financial Report - Dec 2025 Half Year 27 Feb 2026 8:32AM $0.069 $0.018 fallen by 73.91%
$9 Change in substantial holding 9 Feb 2026 5:16PM $0.076 $0.018 fallen by 76.32%
$9 Application for quotation of securities - CVB 5 Feb 2026 8:21AM $0.081 $0.018 fallen by 77.78%
$9 Euroz Hartleys 2026 Healthcare Forum Presentation 5 Feb 2026 8:21AM $0.081 $0.018 fallen by 77.78%

1 - 25 of 285 results

Page 1 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.